• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-7.0-120-PTX
Device Problem Occlusion Within Device (1423)
Patient Problem Reocclusion (1985)
Event Date 06/22/2017
Event Type  Injury  
Manufacturer Narrative
Pma/510(k) # p100022/s001.(b)(4).Device evaluation: two ziv6-35-125-7.0-120-ptx stents of lot number c782594 were implanted in the patient and are therefore unavailable for evaluation.With the information provided a document based investigation was carried out.It was stated by the originator in the complaint file that there are no images available for review.The patient had the following pre-existing conditions at the time of the procedure: diabetes (type ii) and renal disease (renal failure) there is no evidence to suggest that this event did not occur, therefore the complaint is confirmed based on customer testimony.Restenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During percutaneous transluminal angioplasty (pta) and/or stenting).Vessel injury provokes an inflammatory response that leads to (or amplifies) the restenosis process.It may be noted that surface of the zilver ptx stent is coated with the drug (paclitaxel) to help prevent subsequent restenosis of the artery.It can be therefore stated that it is very unlikely that the reported restenosis could have occurred due to zilver ptx malfunction; however as no imaging was available at the time of investigation, a definitive root cause of this event cannot be determined at this time.Worsened claudication was also observed on the patient.It can be noted that this symptom indicates progression of peripheral artery disease and can also be associated with the restenosis process.It may be noted that the packaging insert lists restenosis of the stented artery as a known potential adverse event associated with placement of this device.In addition worsened claudication is also listed as a potential adverse event associated with the placement in this device as per the packaging insert document review: the ziv6-35-125-7.0-120-ptx stents of lot number c782594 contain zilver ptx drug eluting stent zvsp6-125-7.0-120-is of lot number ch765034.A review of the relevant manufacturing records ((b)(4)) revealed no discrepancies that could have contributed to this complaint.Summary: there is no evidence to suggest that this event did not occur, therefore the complaint is confirmed based on customer testimony.Pta and additional stent placement with zilver ptx or flex were performed.The patient had a favourable outcome.The risk associated with the complaint is moderate.No immediate action is required.Complaints of this nature will continue to be monitored for any potential emerging trends.
 
Event Description
On (b)(6) 2012: two stents (ziv6-35-125-7.0-120-ptx/ c782594 x2) were placed in the right sfa.On (b)(6) 2017: restenosis was confirmed in the lesion.(worsen claudication and worsen rutherford were observed.) then, pta and additional stent placement with zilver ptx or flex were performed.The patient had a favourable outcome.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer Contact
michael galvin
o halloran road
national technology park
limerick 
061334440
MDR Report Key7024397
MDR Text Key91916565
Report Number3001845648-2017-00524
Device Sequence Number1
Product Code NIU
UDI-Device Identifier10827002513539
UDI-Public(01)10827002513539(17)140516(10)C782594
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 10/16/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-7.0-120-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date11/13/2017
Event Location Hospital
Initial Date Manufacturer Received 10/16/2017
Initial Date FDA Received11/13/2017
Date Device Manufactured07/03/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-